BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 35997171)

  • 1. A Preliminary Study on Investigation of Blood-Brain Barrier Damage Markers in Patients with Alcohol Use Disorder Before and After Therapy.
    Cetin I; Yazla E; Akmese B; Kayadibi H
    Alcohol Alcohol; 2022 Nov; 57(6):722-726. PubMed ID: 35997171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Changes in Peripheric Biomarkers Related to Blood Brain Barrier Damage in Patients with Schizophrenia and Their Correlation with Symptoms.
    Yazla E; Kayadibi H; Cetin I; Aydinoglu U; Karadere ME
    Clin Psychopharmacol Neurosci; 2022 Aug; 20(3):504-513. PubMed ID: 35879035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different expression of ubiquitin C-terminal hydrolase-L1 and αII-spectrin in ischemic and hemorrhagic stroke: Potential biomarkers in diagnosis.
    Ren C; Zoltewicz S; Guingab-Cagmat J; Anagli J; Gao M; Hafeez A; Li N; Cao J; Geng X; Kobeissy F; Mondello S; Larner SF; Hayes RL; Ji X; Ding Y
    Brain Res; 2013 Dec; 1540():84-91. PubMed ID: 24140110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrix metalloproteinase-2 and -9 secreted by leukemic cells increase the permeability of blood-brain barrier by disrupting tight junction proteins.
    Feng S; Cen J; Huang Y; Shen H; Yao L; Wang Y; Chen Z
    PLoS One; 2011; 6(8):e20599. PubMed ID: 21857898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum claudin-5, claudin-11, occludin, vinculin, paxillin, and beta-catenin levels in preschool children with autism spectrum disorder.
    Bilgiç A; Ferahkaya H; Karagöz H; Kılınç İ; Energin VM
    Nord J Psychiatry; 2023 Jul; 77(5):506-511. PubMed ID: 36662163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-27a-3p regulates expression of intercellular junctions at the brain endothelium and controls the endothelial barrier permeability.
    Harati R; Hammad S; Tlili A; Mahfood M; Mabondzo A; Hamoudi R
    PLoS One; 2022; 17(1):e0262152. PubMed ID: 35025943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarkers track damage after graded injury severity in a rat model of penetrating brain injury.
    Zoltewicz JS; Mondello S; Yang B; Newsom KJ; Kobeissy F; Yao C; Lu XC; Dave JR; Shear DA; Schmid K; Rivera V; Cram T; Seaney J; Zhang Z; Wang KK; Hayes RL; Tortella FC
    J Neurotrauma; 2013 Jul; 30(13):1161-9. PubMed ID: 23409698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated serum ubiquitin carboxy-terminal hydrolase L1 is associated with abnormal blood-brain barrier function after traumatic brain injury.
    Blyth BJ; Farahvar A; He H; Nayak A; Yang C; Shaw G; Bazarian JJ
    J Neurotrauma; 2011 Dec; 28(12):2453-62. PubMed ID: 21428722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix metalloproteinase-2-mediated occludin degradation and caveolin-1-mediated claudin-5 redistribution contribute to blood-brain barrier damage in early ischemic stroke stage.
    Liu J; Jin X; Liu KJ; Liu W
    J Neurosci; 2012 Feb; 32(9):3044-57. PubMed ID: 22378877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum concentrations of ubiquitin C-terminal hydrolase-L1 and αII-spectrin breakdown product 145 kDa correlate with outcome after pediatric TBI.
    Berger RP; Hayes RL; Richichi R; Beers SR; Wang KK
    J Neurotrauma; 2012 Jan; 29(1):162-7. PubMed ID: 22022780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of the α7 nicotinic acetylcholine receptor upregulates blood-brain barrier function through increased claudin-5 and occludin expression in rat brain endothelial cells.
    Kimura I; Dohgu S; Takata F; Matsumoto J; Kawahara Y; Nishihira M; Sakada S; Saisho T; Yamauchi A; Kataoka Y
    Neurosci Lett; 2019 Feb; 694():9-13. PubMed ID: 30452951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Very Early Serum Levels of S100B, Glial Fibrillary Acidic Protein, Ubiquitin C-Terminal Hydrolase-L1, and Spectrin Breakdown Product with Outcome in ProTECT III.
    Frankel M; Fan L; Yeatts SD; Jeromin A; Vos PE; Wagner AK; Wolf BJ; Pauls Q; Lunney M; Merck LH; Hall CL; Palesch YY; Silbergleit R; Wright DW
    J Neurotrauma; 2019 Oct; 36(20):2863-2871. PubMed ID: 30794101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temporal response profiles of serum ubiquitin C-terminal hydrolase-L1 and the 145-kDa alpha II-spectrin breakdown product after severe traumatic brain injury in children.
    Metzger RR; Sheng X; Niedzwecki CM; Bennett KS; Morita DC; Zielinski B; Schober ME
    J Neurosurg Pediatr; 2018 Oct; 22(4):369-374. PubMed ID: 29957142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethanol-induced activation of myosin light chain kinase leads to dysfunction of tight junctions and blood-brain barrier compromise.
    Haorah J; Heilman D; Knipe B; Chrastil J; Leibhart J; Ghorpade A; Miller DW; Persidsky Y
    Alcohol Clin Exp Res; 2005 Jun; 29(6):999-1009. PubMed ID: 15976526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of hydrocortisone and TNFalpha on tight junction proteins in an in vitro model of the human blood-brain barrier.
    Förster C; Burek M; Romero IA; Weksler B; Couraud PO; Drenckhahn D
    J Physiol; 2008 Apr; 586(7):1937-49. PubMed ID: 18258663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of alpha-II-spectrin breakdown products as potential biomarkers for early recognition and severity of aneurysmal subarachnoid hemorrhage.
    Papa L; Rosenthal K; Silvestri F; Axley JC; Kelly JM; Lewis SB
    Sci Rep; 2018 Sep; 8(1):13308. PubMed ID: 30190542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased caveolin-1 expression precedes decreased expression of occludin and claudin-5 during blood-brain barrier breakdown.
    Nag S; Venugopalan R; Stewart DJ
    Acta Neuropathol; 2007 Nov; 114(5):459-69. PubMed ID: 17687559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessments of tight junction proteins occludin, claudin 5 and scaffold proteins ZO1 and ZO2 in endothelial cells of the rat blood-brain barrier: cellular responses to neurotoxicants malathion and lead acetate.
    Balbuena P; Li W; Ehrich M
    Neurotoxicology; 2011 Jan; 32(1):58-67. PubMed ID: 20970449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autophagy-mediated occludin degradation contributes to blood-brain barrier disruption during ischemia in bEnd.3 brain endothelial cells and rat ischemic stroke models.
    Kim KA; Kim D; Kim JH; Shin YJ; Kim ES; Akram M; Kim EH; Majid A; Baek SH; Bae ON
    Fluids Barriers CNS; 2020 Mar; 17(1):21. PubMed ID: 32169114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific role of tight junction proteins claudin-5, occludin, and ZO-1 of the blood-brain barrier in a focal cerebral ischemic insult.
    Jiao H; Wang Z; Liu Y; Wang P; Xue Y
    J Mol Neurosci; 2011 Jun; 44(2):130-9. PubMed ID: 21318404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.